FCA Health Innovations Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
New Fund
FCA Health Innovations III filings targeted a $175M equity raise, with at least $49.8M raised as of the May 2026 filing.
FCA Health Innovations III
Participated in BranchLab's $26M Series A for AI-enabled pharma commercialization.
Essay
Published a thesis report on Epic's acute-care technology footprint and white space for complementary healthcare vendors.
Navigating the Epic Ecosystem
Essay
Published a thesis report on technology-enabled pharma commercialization infrastructure and access workflows.
How Economic Pressure and Access Constraints Are Reshaping Pharma's Go-to-Market Model
Milestone
Portfolio company Azra AI acquired Thynk Health to expand imaging-driven oncology and incidental findings workflows.
Azra AI
Investment
Coral Care raised $13M in Series A funding to expand in-home pediatric therapy services, with participation from FCA Ventures.
Coral Care
Milestone
Impiricus claimed the #1 spot on Deloitte's 2025 Technology Fast 500 with a growth rate of 29,738% from 2021-2024.
Impiricus
Exit
Portfolio company eBlu Solutions was acquired by Knipper Health to create an industry-leading therapy initiation platform.
eBlu Solutions